| Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 … J Stumpf, T Siepmann, T Lindner, C Karger, J Schwöbel, L Anders, ... The Lancet Regional Health–Europe 9, 2021 | 312 | 2021 |
| Ferroptosis and necroptosis in the kidney A Belavgeni, C Meyer, J Stumpf, C Hugo, A Linkermann Cell chemical biology 27 (4), 448-462, 2020 | 216 | 2020 |
| Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS) U Platzbecker, M Bornhäuser, U Germing, J Stumpf, BL Scott, N Kröger, ... Biology of Blood and Marrow Transplantation 14 (11), 1217-1225, 2008 | 164 | 2008 |
| Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis A Belavgeni, SR Bornstein, A Von Mässenhausen, W Tonnus, J Stumpf, ... Proceedings of the National Academy of Sciences 116 (44), 22269-22274, 2019 | 99 | 2019 |
| Cellular and humoral immune responses after 3 doses of BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant J Stumpf, W Tonnus, A Paliege, R Rettig, A Steglich, F Gembardt, ... Transplantation 105 (11), e267-e269, 2021 | 80 | 2021 |
| A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse TH Westhoff, FS Seibert, M Anft, A Blazquez-Navarro, S Skrzypczyk, ... Kidney International 100 (5), 1135, 2021 | 46 | 2021 |
| Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial N Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ... The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024 | 38 | 2024 |
| Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ... The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024 | 35 | 2024 |
| Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study J Stumpf, J Schwöbel, T Lindner, L Anders, T Siepmann, C Karger, ... The Lancet Regional Health–Europe 17, 2022 | 23 | 2022 |
| Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients M Graninger, J Stumpf, G Bond, I Görzer, DN Springer, F Kessel, H Kröger, ... Journal of Clinical Virology 162, 105428, 2023 | 15 | 2023 |
| vPIF-1 is an insulin-like antiferroptotic viral peptide A Belavgeni, F Maremonti, W Tonnus, M Stadtmüller, S Gavali, M Mallais, ... Proceedings of the National Academy of Sciences 120 (21), e2300320120, 2023 | 12 | 2023 |
| MMF/MPA is the main mediator of a delayed humoral response with reduced antibody decline in kidney transplant recipients after SARS-CoV-2 mRNA vaccination J Stumpf, T Siepmann, J Schwöbel, G Glombig, A Paliege, A Steglich, ... Frontiers in Medicine 9, 928542, 2022 | 12 | 2022 |
| Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study) J Stumpf, O Thomusch, M Opgenoorth, M Wiesener, A Pascher, ... Nephrology Dialysis Transplantation 39 (1), 141-150, 2024 | 8 | 2024 |
| Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA … J Stumpf, A Klimova, R Mauer, A Steglich, F Gembardt, H Martin, ... Nephrology Dialysis Transplantation 37 (4), 796-798, 2022 | 7 | 2022 |
| New automatic quantification method of immunofluorescence and histochemistry in whole histological sections F Kessel, A Steglich, T Tschongov, F Gembardt, L Ruhnke, J Stumpf, ... Cellular Signalling 62, 109335, 2019 | 7 | 2019 |
| Anti-SARS-CoV-2 revaccination success in kidney transplant recipients with no initial humoral response is linked to primary vaccine type J Stumpf, J Schwöbel, C Karger, H Schirutschke, R Mauer, A Klimova, ... Frontiers in Medicine 9, 910987, 2022 | 6 | 2022 |
| 9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients J Stumpf, L Anders, T Siepmann, J Schwöbel, C Karger, T Lindner, ... Vaccine 42 (2), 120-128, 2024 | 3 | 2024 |
| Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective … J Stumpf, K Budde, O Witzke, C Sommerer, T Vogel, P Schenker, ... EClinicalMedicine 67, 2024 | 2 | 2024 |
| The Impact of Transfusion-Dependency on the Outcome of Patients with Myelodysplastic Syndromes (MDS) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation after … U Platzbecker, U Germing, J Stumpf, N Kröger, A Böhm, P Valent, ... Blood 110 (11), 1467, 2007 | 2 | 2007 |
| Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantation J de Fallois, A Günzel, C Daniel, J Stumpf, M Busch, U Pein, A Paliege, ... American Journal of Transplantation, 2024 | 1 | 2024 |
